Rabia A. Gilani

442 total citations
17 papers, 319 citations indexed

About

Rabia A. Gilani is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Rabia A. Gilani has authored 17 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Rabia A. Gilani's work include Estrogen and related hormone effects (3 papers), Stress Responses and Cortisol (2 papers) and Advanced Breast Cancer Therapies (2 papers). Rabia A. Gilani is often cited by papers focused on Estrogen and related hormone effects (3 papers), Stress Responses and Cortisol (2 papers) and Advanced Breast Cancer Therapies (2 papers). Rabia A. Gilani collaborates with scholars based in United States, India and Pakistan. Rabia A. Gilani's co-authors include Zahoor A. Shah, Pragya Sharma, S. B. Vohora, Angela Brodie, Armina A. Kazi, Gauri Sabnis, Saranya Chumsri, Preeti Shah, Olga Goloubeva and Zahoor Ahmad and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Journal of Controlled Release.

In The Last Decade

Rabia A. Gilani

14 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rabia A. Gilani United States 10 132 73 54 53 36 17 319
Hsiao‐Fung Pu Taiwan 12 239 1.8× 40 0.5× 69 1.3× 40 0.8× 26 0.7× 21 560
Yun Feng China 11 218 1.7× 39 0.5× 39 0.7× 28 0.5× 52 1.4× 21 528
Ki‐Shuk Shim South Korea 12 212 1.6× 49 0.7× 29 0.5× 49 0.9× 53 1.5× 40 389
Yu‐Ting Weng Taiwan 11 220 1.7× 43 0.6× 68 1.3× 18 0.3× 30 0.8× 24 438
Shuguang Yan China 13 252 1.9× 28 0.4× 89 1.6× 37 0.7× 23 0.6× 34 463
Yanju Gong China 9 115 0.9× 29 0.4× 28 0.5× 26 0.5× 19 0.5× 31 295
Huiting Fan China 7 128 1.0× 33 0.5× 29 0.5× 39 0.7× 25 0.7× 12 321
Tai Van Nguyen Vietnam 9 106 0.8× 46 0.6× 44 0.8× 94 1.8× 19 0.5× 30 332
Alessandra Toti Italy 13 232 1.8× 86 1.2× 74 1.4× 23 0.4× 23 0.6× 32 498
Jong-Hoon Ryu South Korea 9 355 2.7× 63 0.9× 123 2.3× 46 0.9× 71 2.0× 18 537

Countries citing papers authored by Rabia A. Gilani

Since Specialization
Citations

This map shows the geographic impact of Rabia A. Gilani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rabia A. Gilani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rabia A. Gilani more than expected).

Fields of papers citing papers by Rabia A. Gilani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rabia A. Gilani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rabia A. Gilani. The network helps show where Rabia A. Gilani may publish in the future.

Co-authorship network of co-authors of Rabia A. Gilani

This figure shows the co-authorship network connecting the top 25 collaborators of Rabia A. Gilani. A scholar is included among the top collaborators of Rabia A. Gilani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rabia A. Gilani. Rabia A. Gilani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gilani, Rabia A., et al.. (2024). True brachial artery aneurysm: A systematic review. SHILAP Revista de lepidopterología. 74(2). 341–365. 2 indexed citations
2.
Gilani, Rabia A., et al.. (2023). Treatment of superior mesenteric artery mycotic aneurysm by synthetic vascular graft: a case report. SHILAP Revista de lepidopterología. 73(4). 925–928.
5.
Shahid, Muhammad, Muhammad Tariq Javed, Samina Masood, et al.. (2019). Serratiasp.CP‐13 augments the growth of cadmium (Cd)‐stressedLinum usitatissimumL. by limited Cd uptake, enhanced nutrient acquisition and antioxidative potential. Journal of Applied Microbiology. 126(6). 1708–1721. 27 indexed citations
6.
Tiruchinapally, Gopinath, Yasemin Yüksel Durmaz, Liwei Bao, et al.. (2018). Synergistic inhibition of aggressive breast cancer cell migration and invasion by cytoplasmic delivery of anti-RhoC silencing RNA and presentation of EPPT1 peptide on “smart” particles. Journal of Controlled Release. 289. 79–93. 13 indexed citations
7.
Jiagge, Evelyn, Jessica Bensenhaver, Mark J. Hoenerhoff, et al.. (2018). Creating Models to Identify New Therapeutic Options for Aggressive African Breast Cancers. Journal of Global Oncology. 4(Supplement 2). 206s–206s. 1 indexed citations
8.
Kazi, Armina A., Rabia A. Gilani, Saranya Chumsri, et al.. (2014). Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer. Breast Cancer Research. 16(1). R15–R15. 33 indexed citations
9.
Kazi, Armina A., et al.. (2013). Zoledronic Acid Reverses the Epithelial–Mesenchymal Transition and Inhibits Self-Renewal of Breast Cancer Cells through Inactivation of NF-κB. Molecular Cancer Therapeutics. 12(7). 1356–1366. 26 indexed citations
10.
Gilani, Rabia A., Armina A. Kazi, Preeti Shah, et al.. (2012). The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer. Breast Cancer Research and Treatment. 135(3). 681–692. 31 indexed citations
11.
Sabnis, Gauri, Olga Goloubeva, Rabia A. Gilani, Luciana F. Macedo, & Angela Brodie. (2010). Sensitivity to the Aromatase Inhibitor Letrozole Is Prolonged After a “Break” in Treatment. Molecular Cancer Therapeutics. 9(1). 46–56. 21 indexed citations
12.
Sabnis, Gauri, Olga Goloubeva, Rabia A. Gilani, et al.. (2009). Expression of ERα and Aromatase in MDA-MB-231 Tumors by HDAC Inhibitor Entinostat Leads to Growth Inhibition by Aromatase Inhibitor Letrozole.. Cancer Research. 69(24_Supplement). 401–401. 4 indexed citations
13.
Goloubeva, Olga, et al.. (2009). Combination of HDACi entinostat (SNDX-275) with letrozole provides control over tumor growth in MDA-MB-231 xenograft model.. Cancer Research. 69(2_Supplement). 6128–6128. 4 indexed citations
14.
Nadeem, Ahmed, et al.. (2005). Immobilization stress causes extra-cellular oxidant–antioxidant imbalance in rats: Restoration by L-NAME and vitamin E. European Neuropsychopharmacology. 16(4). 260–267. 32 indexed citations
15.
Ahmad, Zahoor, Rabia A. Gilani, Pragya Sharma, & S. B. Vohora. (2005). Attenuation of Stress‐Elicited Brain Catecholamines, Serotonin and Plasma Corticosterone Levels by Calcined Gold Preparations Used in Indian System of Medicine. Basic & Clinical Pharmacology & Toxicology. 96(6). 469–474. 28 indexed citations
16.
Shah, Zahoor A., Rabia A. Gilani, Pragya Sharma, & S. B. Vohora. (2005). Cerebroprotective effect of Korean ginseng tea against global and focal models of ischemia in rats. Journal of Ethnopharmacology. 101(1-3). 299–307. 68 indexed citations
17.
Shah, Zahoor A., Rabia A. Gilani, Pragya Sharma, & S. B. Vohora. (2005). Attenuation of Stress-Elicited Brain Catecholamines, Serotonin and Plasma Corticosterone Levels by Calcined Gold Preparations Used in Indian System of Medicine. Basic & Clinical Pharmacology & Toxicology. 96(6). 469–474. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026